Ingmar Gorman

1.3k total citations
8 papers, 244 citations indexed

About

Ingmar Gorman is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Ingmar Gorman has authored 8 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Psychology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Ingmar Gorman's work include Psychedelics and Drug Studies (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Cannabis and Cannabinoid Research (3 papers). Ingmar Gorman is often cited by papers focused on Psychedelics and Drug Studies (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Cannabis and Cannabinoid Research (3 papers). Ingmar Gorman collaborates with scholars based in United States, Czechia and Ireland. Ingmar Gorman's co-authors include Jonathan J. Sabbagh, Elizabeth M. Nielson, Martin Brunovský, Filip Tylš, Jiřı́ Horáček, Tomáš Páleníček, Vĕra Bubeníková‐Valešová, Marie Balı́ková, Cyril Höschl and Vladimı́r Krajča and has published in prestigious journals such as Psychopharmacology, Frontiers in Psychology and Pharmacology Biochemistry and Behavior.

In The Last Decade

Ingmar Gorman

6 papers receiving 239 citations

Peers

Ingmar Gorman
Allison R. Coker United States
Hannah M. Kramer United States
B. Thelen Germany
Nick Walker United States
Robin von Rotz Switzerland
Ingmar Gorman
Citations per year, relative to Ingmar Gorman Ingmar Gorman (= 1×) peers Yasmin Padovan‐Hernandez

Countries citing papers authored by Ingmar Gorman

Since Specialization
Citations

This map shows the geographic impact of Ingmar Gorman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingmar Gorman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingmar Gorman more than expected).

Fields of papers citing papers by Ingmar Gorman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingmar Gorman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingmar Gorman. The network helps show where Ingmar Gorman may publish in the future.

Co-authorship network of co-authors of Ingmar Gorman

This figure shows the co-authorship network connecting the top 25 collaborators of Ingmar Gorman. A scholar is included among the top collaborators of Ingmar Gorman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingmar Gorman. Ingmar Gorman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Thomas, Chantelle, et al.. (2025). Relationality and Ethics in MDMA-Assisted Therapy. The American Journal of Bioethics. 25(1). 67–71.
2.
Gorman, Ingmar, et al.. (2024). Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Current topics in behavioral neurosciences.
3.
Gorman, Ingmar, et al.. (2021). Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice. Frontiers in Psychology. 12. 86 indexed citations
4.
Gorman, Ingmar, Alexander Belser, Lisa Jerome, et al.. (2020). Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Traumatic Stress. 33(2). 161–170. 31 indexed citations
5.
Páleníček, Tomáš, Martin Brunovský, Ingmar Gorman, et al.. (2014). The effect of ((−)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis. Pharmacology Biochemistry and Behavior. 122. 212–221. 15 indexed citations
6.
Kelly, Michael, et al.. (2014). Investigation of the mechanisms mediating MDMA “Ecstasy”-induced increases in cerebro-cortical perfusion determined by btASL MRI. Psychopharmacology. 232(9). 1501–1513. 3 indexed citations
7.
Páleníček, Tomáš, Martin Brunovský, Jiřı́ Horáček, et al.. (2012). Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology. 225(1). 75–93. 37 indexed citations
8.
Páleníček, Tomáš, Martin Brunovský, Marie Balı́ková, et al.. (2011). Electroencephalographic Spectral and Coherence Analysis of Ketamine in Rats: Correlation with Behavioral Effects and Pharmacokinetics. Neuropsychobiology. 63(4). 202–218. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026